ENTITY Pfizer-BioNTech COVID-19 BNT162b2 Vaccine Effectiveness Study - Kaiser Permanente Southern California

Pfizer-BioNTech COVID-19 BNT162b2 Vaccine Effectiveness Study - Kaiser Permanente Southern California

PulseAugur coverage of Pfizer-BioNTech COVID-19 BNT162b2 Vaccine Effectiveness Study - Kaiser Permanente Southern California — every cluster mentioning Pfizer-BioNTech COVID-19 BNT162b2 Vaccine Effectiveness Study - Kaiser Permanente Southern California across labs, papers, and developer communities, ranked by signal.

Show in brief

Total · 30d

1 over 90d

Releases · 30d

0 over 90d

Papers · 30d

0 over 90d

TIER MIX · 90D

TOPICS

other 1

SENTIMENT · 30D

1 day(s) with sentiment data

RECENT · PAGE 1/1 · 1 TOTAL

COMMENTARY · CL_287974 · Oct 8 · 12:00

Vaccines proven effective in preventing millions of disease cases

Vaccines have a long and successful history of preventing infectious diseases, saving millions of lives and averting numerous cases of illness. From smallpox and polio to measles and COVID-19, vaccination campaigns have…

Vaccines proven effective in preventing millions of disease cases